StockWatch
·

Aarti Surfactants Ltd Q2 FY27 Results

AARTISURFQ2 FY27 Results
Filing
Result:Good· Market: Surged#Base effect#Margin expansion#Cost led#Record quarter
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue291.246.7%62.5%
Total Income291.386.7%62.6%
Expenditure269.923.5%52.5%
PBT17.1640.8%681.5%
Net Profit12.5038.9%703.4%
OPM8.79%1.36pp3.57pp
NPM4.29%0.99pp3.42pp
EPS14.7638.9%702.2%
View full financials

Revenue grew a strong 62.6% YoY to a 6-quarter high with genuine cost-led OPM expansion (5.2%→10.2%), but the headline PAT jump is heavily flattered by a depressed year-ago base and a one-off customs penalty muddies the reported number, capping it short of very_good.

Q2 FY-2027 RESULTS · AARTISURF

Aarti Surfactants Q2 FY27: consolidated PAT ₹12.5 Cr, margins expand off weak base

PAT +703.4% YoY · revenue +62.56% · margins expanding

14 Nov 2026 · 3 min read
Revenue

₹291.24 Cr

+62.56% YoY

PAT (consolidated)

₹12.5 Cr

+703.4% YoY

Net margin

4.29%

+3.4pp YoY

EPS

₹14.76

Aarti Surfactants' consolidated revenue rose 62.6% YoY to ₹291.24 Cr in Q2 FY27 (from ₹179.17 Cr in Q2 FY26) and 6.7% QoQ (from ₹272.87 Cr in Q1 FY27). Consolidated PAT came in at ₹12.50 Cr, up from ₹1.56 Cr a year ago and ₹9.00 Cr last quarter — but the reported YoY PAT jump (+703%) is flattered by an unusually weak year-ago base, when NPM was just 0.87%. Adjusting for this quarter's ₹4.30 Cr exceptional charge, PAT would have been ~₹16.80 Cr (NPM ~5.8%), putting underlying YoY profit growth near ~980% — still base-driven, but confirming the improvement isn't purely a one-off reversal.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹291.24 Cr+6.7%+62.6%
Expenses₹269.92 Cr+3.5%+52.5%
PAT₹12.5 Cr+38.91%+703.4%
Net margin4.29%+1pp+3.4pp
EPS₹14.76+38.9%+702.2%

The more durable signal is operating leverage: consolidated OPM nearly doubled YoY to 10.22% from 5.23% in Q2 FY26, and improved from 7.48% in Q1 FY27, as cost of materials consumed fell to 84.7% of revenue from 97.1% a year earlier — a cost-structure shift management has not yet explained publicly (no press release was available with this filing). Reported NPM rose to 4.29% from 0.87% YoY despite absorbing the ₹4.30 Cr exceptional provision, of which the ₹2.83 Cr customs duty/penalty component ties directly to the "Customs Duty, Fine, and Penalty Order" the company flagged on 25 September 2026. A related ₹6.71 Cr customs demand from an earlier show-cause notice remains an unprovided contingent liability, pending adjudication.

₹
420.69486.85553619.15685.3153008-1109-0109-2410-1911-1111-13
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹530, up 7.3% over the past month of trading.

₹ Cr
04.679.34142.94Q1 FY26rev ₹216 Cr1.56Q2 FY26rev ₹179 Cr3.66Q3 FY26rev ₹208 Cr4.19Q4 FY26rev ₹256 Cr9Q1 FY27rev ₹273 Cr12.5Q2 FY27rev ₹291 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 4 consecutive quarters; revenue is at a 6-quarter high.

Beyond the headline

What the summary numbers don't show

Consolidated basic EPS ₹14.76 vs ₹1.84 a year ago and ₹10.63 last quarter

The company has no formal guidance on record, and no published sell-side estimates for this specific quarter turned up in search, so the print cannot be benchmarked against either a management target or street consensus — both read as unknown here. Alongside the results, the quarter also saw board/AGM activity: shareholders approved an MOA alteration (1 October 2026), the board reappointed key managerial personnel and added a new director following an earlier director's resignation (12 September, cited time commitments), and CRISIL upgraded the long-term bank facility rating to A-/Stable from CARE's BBB+/Stable (3 September 2026) — alongside the ₹23.23 Cr redemption of all outstanding non-convertible preference shares out of profits on 5 August 2026.

  • W1

    ₹6.71 Cr contingent customs duty matter (DRI show-cause, pending adjudication) — whether it crystallizes into a further provision in coming quarters

  • W2

    Durability of the raw-material cost ratio improvement (84.7% of revenue this quarter vs 97.1% a year ago) into Q3 FY27

  • W3

    Whether OPM holds near the ~10% level reached this quarter or reverts toward the 5-7.5% band seen in the trailing four quarters

Both statements unaudited (limited review); current quarter carries a ₹4.30 Cr exceptional charge (₹1.47 Cr stamp duty on a scheme of demerger + ₹2.83 Cr customs duty/interest/penalty under a DRI order) absent in the year-ago quarter; standalone vs consolidated PAT differ by <1% (consolidation adds dormant US subsidiary Precision Ingredients USA Inc., not yet operational, and Aarti HPC Limited).

Informational and educational content only. Not investment advice.